These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17169776)

  • 1. Cancer vaccines: toward the next revolution in cancer therapy.
    Emens LA
    Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting cancer therapy.
    Begent RH
    Br J Cancer; 1999 Jul; 80 Suppl 1():104-9. PubMed ID: 10466768
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
    Sznol M
    Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
    [No Abstract]   [Full Text] [Related]  

  • 4. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capacity of the immune system to control cancer.
    Håkansson L
    Eur J Cancer; 2009 Aug; 45(12):2068-70. PubMed ID: 19608409
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy.
    Croix BS
    Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy].
    Van den Eynde B
    Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer vaccines: pessimism in check.
    Timmerman JM; Levy R
    Nat Med; 2004 Dec; 10(12):1279; author reply 1279-80. PubMed ID: 15682512
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the efficacy of cancer immunotherapy.
    Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
    Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
    Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
    Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 16. Dendritic cells in cancer immunotherapy.
    Vulink A; Radford KJ; Melief C; Hart DN
    Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical challenges facing therapeutic cancer vaccines.
    Ward S; Copier J; Dalgleish A
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):168-77. PubMed ID: 18283604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges for cancer vaccine development.
    Tabi Z; Man S
    Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BCG-CWS as a cancer vaccine].
    Hayashi A
    Nihon Rinsho; 2002 May; 60 Suppl 5():614-20. PubMed ID: 12101748
    [No Abstract]   [Full Text] [Related]  

  • 20. A bright future for cancer vaccines. Success in early trials suggests vaccines are the next step in cancer treatment.
    Duke Med Health News; 2008 Oct; 14(10):4-5. PubMed ID: 18927992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.